MaxCyte Inc (MXCT) — Cash Flow-to-Debt Ratio
MaxCyte Inc (MXCT) has a Cash Flow-to-Debt Ratio of -0.22x as of September 2025, meaning its operating cash flow of $-7.46 Million could theoretically repay 0% of its total liabilities ($33.20 Million) in one year. See MaxCyte Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
MaxCyte Inc Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for MaxCyte Inc across 13 annual periods. Also explore MXCT net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for MaxCyte Inc (2012–2024)
Year-by-year debt coverage analysis for MaxCyte Inc. For market capitalisation and broader financial context, see MXCT market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.83x | $-27.61 Million | $33.22 Million | ▼ -38.4% |
| 2023 | -0.60x | $-21.69 Million | $36.11 Million | ▼ -32.8% |
| 2022 | -0.45x | $-14.78 Million | $32.69 Million | ▲ +10.1% |
| 2021 | -0.50x | $-10.68 Million | $21.22 Million | ▼ -6.3% |
| 2020 | -0.47x | $-8.78 Million | $18.55 Million | ▲ +11.9% |
| 2019 | -0.54x | $-8.80 Million | $16.38 Million | ▲ +38.6% |
| 2018 | -0.87x | $-10.49 Million | $11.99 Million | ▼ -6.7% |
| 2017 | -0.82x | $-9.68 Million | $11.80 Million | ▼ -285.9% |
| 2016 | -0.21x | $-2.33 Million | $10.99 Million | ▼ -1016.4% |
| 2015 | -0.02x | $-180.50K | $9.48 Million | ▲ +92.1% |
| 2014 | -0.24x | $-1.93 Million | $7.95 Million | ▼ -75.8% |
| 2013 | -0.14x | $-557.80K | $4.05 Million | ▲ +77.7% |
| 2012 | -0.62x | $-2.13 Million | $3.43 Million | — |